alexa Synthesis of Aryl Tetralone Derivatives by Chalcone Route | Open Access Journals
ISSN: 2161-0444
Medicinal Chemistry
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Synthesis of Aryl Tetralone Derivatives by Chalcone Route

Chaitramallu M1*, Dakshayinichandrashekarachar2, Devaraju Kesagodu1, Rekha ND3 and Ranjini P4

1Department of Chemistry, University of Mysore, Yuvaraja’s College, Mysore, Karnataka, India

2Department of Chemistry, Government College for Women, Mandya, Karnataka, India

3Department of Biotechnology, JSS College of Arts, Commerce and Science, Mysore, Karnataka, India

4Department of Biotechnology, Maharani’s Science College for Women, Mysore, Karnataka, India

*Corresponding Author:
Chaitramallu M
Department of Chemistry, University of Mysore
Yuvaraja’s College, Mysore-570 006, Karnataka, India
Tel: +918050648362
E-mail: [email protected]

Received date: July 15, 2016; Accepted date: July 20, 2016; Published date: July 26, 2016

Citation: Chaitramallu M, Dakshayinichandrashekarachar, Kesagodu D, Rekha ND, Ranjini P (2016) Synthesis of Aryl Tetralone Derivatives by Chalcone Route. Med Chem (Los Angeles) 6:525-530. doi:10.4172/2161-0444.1000393

Copyright: © 2016 Chaitramallu M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Medicinal Chemistry

Abstract

The tetralone analogues of podophyllotoxin were synthesized by the chalcone route. This route attracts the attention because of its simple operating conditions and easy availability of the chemicals. Initially, chalcones were prepared in high yields by Claisen-Schmidt reaction of acetophenones derivatives with 3,4,5-trimethylthoxybenzaldehyde. The cyclopropyl ketones were prepared in good yields by Simmon-Smith reaction of chalcones with diiodomethane with Zn-Cu couple in presence of ether. Tetralones were prepared in good yields by the intramolecular cyclization reaction of cyclopropyl ketones in the presence of p-toluene sulphonic acid and acetic anhydride. The structures of the synthesized compounds were confirmed by IR, 1H NMR and Mass spectral technique. The title compounds were screened for their antimitotic and antimicrobial activities.

Keywords

Acetophenones; Chalcones; Cyclopropylketones; Tetralones; Antimitotic activity; Antimicrobial activity

Introduction

Podophyllotoxin (Figure 1) is a potent antimitotic agent [1,2]. Podophyllin is a resinous extract of medicinal plants Podophyllum emodi and Podophyllum peltatum belonging to the family Berbideraceae in which the podophyllotoxin is one of the main constituent [3]. The toxicity of podophyllotoxin liberates as diarrhea, nausea, vomiting. Hence modifications in podophyllotoxin structure are required to reduce its toxicity and to enhance its biological activity [4]. The biologically active and less cytotoxic new tetralone intermediates of podophyllotoxin have been synthesized. The modification of podophyllotoxin structure might enhance the biological activity with favorable solubility and reduced toxicity [5,6]. Some synthesized analogues of podophyllotoxin showed better antibacterial activity. The structures of the synthesized new tetralone compounds were confirmed by IR, 1H-NMR, 13C-NMR and Mass spectral data. They will be screened for biological activities.

medicinal-chemistry-podophyllotoxin

Figure 1: The structure of podophyllotoxin.

It was planned to synthesize analogues of podophyllotoxin by modifying lactone ring-A with some linked to ring A is replaced by dimethoxy, methoxy, methyl, H [7-10]. Chalcones 3a-d were prepared by Claisen-Schmidt reaction of acetophenone 1a-d with 3, 4, 5-trimethoxybenzaldehyde separately in the presence of potassium hydroxide in water-ethanol mixture. Cyclopropyl ketones 4a-d was prepared in good yields by the reaction of chalcones 2a-d with diiodomethane in presence of Zn-Cu couple. The tetralones 5a-d was prepared by cyclization of cyclopropyl ketones 4a-d in presence of p-toluene sulphonic acid and acetic anhydride in dichloromethane. The structures of 5a-d were based on IR, 1H- NMR, 13C NMR, mass spectra and elemental analysis data.

Experimental

Materials and methods

All the reagents and chemicals were purchased from Merck chemicals used without further purification. Melting points were taken in open capillary tubes and are uncorrected. TLC is performed with E. Merck precoated silica gel plates (60F-254) with iodine as a spot developing agent. Acme, India silica gel, 60–120 mesh is used for column chromatography. IR spectra in KBr were recorded on Perkin-Elmer model 683 spectrometers. 1H NMR (400 MHz) and 13C NMR (100 MHz) spectra were recorded CDCl3 solvent containing tetra methyl silane (TMS) as internal references were recorded on Bruker spectrometer; Elemental analyses were performed on a Perkin- Elmer 2400. Mass spectra were obtained by Water-Q-TOF ultima spectrometer. Micro analytical data were obtained by elemental-Vario EL-III (Scheme 1).

medicinal-chemistry-synthesis-tetralones

Scheme 1: Protocol for the synthesis of tetralones (5a–d).

Synthesisof4-(3,4,5-trimethoxyphenyl)-3,4-dihydronaphthalen- 1(2H)-one derivative (5a-d)

General procedure for the synthesis of chalcones: A mixture of acetophenone 14 (a-d) 0.01 mole and 3,4,5-trimethoxybenzaldehyde 0.01 mole were stirred at room temperature in ehanolic solution of potassium hydroxide for 2-3 hours. The formed yellowish crystals were filtered off washed with distilled water, dried and recrystallised from ethanol to give product as yellow crystals.

(E)-1-(3, 4-dimethoxyphenyl)-3-(3, 4, 5-trimethoxyphenyl) prop-2-en-1-one 3a: Color: light yellow solid. Yield: 80.10%. Mp: 98– 100 °C. IR: 3162–2953 (Ar-CH), 1675 (C=O), 1549 (C=C); 1H NMR: 8.01 (1 H, d, J = 8.2, β-CH), 7.67–7.12 (4 H, m, Ar-H), 6.70(2 H, s, Ar-CH), 7.51 (1 H, d, J = 8.2, α-CH), 3.82 (15 H, s, OCH3); 13C NMR: 196.7, 155.5, 153.2, 150.3, 145.3, 130.3, 126.4, 123.2, 122.3, 112.7, 107.5, 60.8, 56.1; MS, m/z: 358.14 (M+). C20H22O6: C, 67.03; H, 6.19 O, 26.79. Found: C, 67.05; H, 6.18; O, 26.78%.

(E)-1-(4-methoxyphenyl)-3-(3, 4, 5-trimethoxyphenyl) prop-2- en-1-one 3b: Color: light yellow solid. Yield: 80.10%. Mp: 98–100 °C. IR: 3162–2953 (Ar-CH), 1675 (C=O), 1549 (C=C); 1H NMR: 8.11–7.12 (6 H, m, Ar-H), 8.01 (1 H, d, J = 8.2, β-CH), 6.77(2 H, s, Ar-CH), 7.61 (1 H, d, J = 8.2, α-CH), 3.82 (12 H, s, OCH3); 13C NMR: 189.7, 166.5, 153.2, 145.3, 138.5, 130.9, 130.8, 130.3, 126.4, 121.3, 114.7, 103.5, 60.8, 56.1, 55.6; MS, m/z: 328.14 (M+). C19H20O5: C, 69.50; H, 6.14 O, 24.37. Found: C, 69.58; H, 6.16; O, 24.38%.

(E)-1-(4-methylphenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en- 1-one 3c: Color: light yellow solid. Yield: 79.25%. Mp: 111–113 °C. IR: 3158–2968 (Ar-CH), 1683 (C=O), 1558 (C=C); 1H NMR: 8.07 (1 H, d, J = 7.5, β-CH), 7.95–7.42 (6 H, m, Ar-H),6.78(2H, s, Ar-CH), 7.59 (1 H, d, J = 7.3, α-CH), 3.89(9H, s, OCH3), 2.32 (3 H, s, CH3); 13C NMR: 189.9, 153.4, 145.3, 144.2, 138.5,134.9, 130.8, 129.8, 129.6, 126.4, 103.8, 60.8,56.9, 21.6; MS, m/z: 312.15 (M+). C19H20O4: C, 73.07; H, 6.48 O, 20.49. Found: C, 73.08; H, 6.49; O, 20.48%.

(E)-1-(4-phenyl)-3-(3, 4, 5-trimethoxyphenyl) prop-2-en-1-one 3d: Color: light yellow solid. Yield: 85.90%. Mp: 95–97 °C. IR: 3150– 2972 (Ar-CH), 1677 (C=O), 1543 (C=C); 1H NMR: 8.05 (d, 1H, J = 7.8, β-CH), 7.89–7.68 (9 H, m, Ar-H), 7.59 (1 H, d, J = 7.8, α-CH),6.78(2 H, s, Ar-CH), 3.92 (9H, s, OCH3); 13C NMR: 189.6, 153.0, 145.1, 138.5, 137.9,134.6,129.3, 126.8, 121.5,103.8, 60.7,56.3; MS, m/z: 298.10 (M+). Anal. calcd. For C18H18O4: C, 72.47; H, 6.08 O, 21.45. Found: C, 72.44; H, 6.09; O, 21.44%.

General procedure for the synthesis of cyclopropyl ketones 4 (ad): Freshly prepared zinc cupper couple 0.5 mole was taken in conical flask which was fitted with a condenser, dropping funnel and magnetic stirrer. 50 ml of ether was added to the Zn-Cu couple followed by a few milliliters of the dihalomethane. The reaction was started immediately which was indicated by bubbles rising from the couple while the stirred suspension was kept at gentle reflux for two minutes. A mixture of chalcone 0.25 mole and the remaining dihalomethane 0.35 mole was added drop wise for 2 hours. The reaction mixture was refluxed for 20-30 hours. After completion of the reaction, the ether solution was decanted slowly from the unchanged couple into a separating funnel containing a mixture of ice and 1n HCl. The ethereal solution was separated, washed with a second portion of ice-HCl mixture, followed by water and finally dried over potassium carbonate.

(3, 4-dimethoxyphenyl)(2-(3, 4, 5-trimethoxyphenyl) cyclopropyl) methanone 4a: Color: dark brown semi-solid. Yield: 76.90%. IR: 3183– 2975 (Ar-CH), 1689 (C=O), 1269 (C–C); 1H NMR: 7.42–7.07 (4 H, m, Ar-H), 6.67(2H, s, Ar-CH), 3.82 (15 H, s, OCH3), 2.10–2.03 (2 H, m, cyclopro-CH), 0.79 (2 H, d, J = 6.3, cyclopro-CH2); 13C NMR: 192.4,154.2, 152.3, 149.7, 137.6, 130.0, 122.1, 111.7, 110.2, 102.4, 60.8, 56.5, 27.4, 25.9, 14.6; MS, m/z: 372.13 (M+). Anal. Calcd. For C20H22O4: C, 67.73; H, 6.59 O, 25.78 Found: C, 67.71; H, 6.58 O, 25.79%.

(4-methoxyphenyl)(2-(3, 4, 5-trimethoxyphenyl) cyclopropyl) methanone 4b: Color: dark brown semi-solid. Yield: 76.90%. IR: 3183– 2975 (Ar-CH), 1689 (C=O), 1269 (C–C); 1H NMR: 7.86–7.01 (4 H, m, Ar-H), 6.67(2H, s, Ar-CH), 3.89 (12H, s, OCH3), 2.10–2.03 (2 H, m, cyclopro-CH), 0.54 (2 H, d, J = 6.3, cyclopro-CH2); 13C NMR: 192.4, 165.1, 152.3, 137.6, 135.6, 129.8, 129.0, 114.2, 102.4, 60.8, 56.1, 55.5, 27.1, 25.8, 14.7; MS, m/z: 342.13 (M+). Anal. Calcd. For C20H22O5: C, 70.16; H, 6.49 O, 23.36 Found: C, 70.15; H, 6.45 O, 23.39%.

(4-methylphenyl)(2-(3, 4, 5-trimethoxyphenyl) cyclopropyl) methanone 4c: Color: dark brown semisolid. Yield: 69.65%. IR: 3186– 2974 (Ar-CH), 1688 (C=O), 1270 (C–C); 1H NMR: 7.37–6.75 (5 H, m, Ar-H), 6.62(2H, s, Ar-CH), 3.58 (9 H, s, OCH3), 2.34 (3 H, s, CH3), 2.18–2.02 (2 H, m, cyclopro-CH), 0.81 (2 H, d, J = 6.6, cyclopro-CH2); 13C NMR: 192.4, 153.1, 142.8, 137.1, 135.3, 133.7, 128.9, 128.7, 102.1. 60.9. 56.1, 27.6, 25.4, 21.3, 14.5; MS, m/z: 326.10 (M+). Anal. Calcd. C20H22O4: C, 73.60; H, 6.79 O, 19.61 Found: C, 73.61; H, 6.75 O, 19.69%.

4-phenyl-(2-(3, 4, 5-trimethoxyphenyl) cyclopropyl) methanone 4d: Color: dark brown semisolid. Yield: 71.40%. IR: 3183–2972 (Ar- CH), 1685 (C=O), 1273 (C–C); 1H NMR: 7.97–7.52 (6 H, m, Ar-H), 6.62(2H, s, Ar-CH), 3.78 (9 H, s, OCH3), 2.16–2.01 (2 H, m, cyclopro-CH),0.54 (2 H, d, J = 6.8, cyclopro-CH2); 13C NMR: 192.9, 152.7, 137.6, 136.7, 135.6, 133.2, 128.8, 128.6, 104.1, 60.9, 56.5, 27.1, 25.8, 14.6, 14.5; MS, m/z: 312.12 (M+). Anal. Calcd. For C20H22O4: C, 73.06; H, 6.49 O, 20.49 Found: C, 73.01; H, 6.50 O, 20.48%.

General procedure for the synthesis of tetralones 5 (a-d)

6, 7-dimethoxy-4-(3, 4, 5-trimethoxyphenyl)-3, 4-dihydronaphthalen- 1(2H)-one 5a: Color: dark brown gummy solid. Yield: 75.18%. IR: 3128– 2939 (Ar-CH), 1697 (C=O); 1H NMR: 7.58–7.05 (4 H, m, Ar-H), 6.52(2 H, s, Ar-H), 4.04 (1 H, t, J = 4.7, CH), 3.83 (15 H, s, OCH3), 2.66–2.25 (4 H, t, J = 6.4, CH2),; 13C NMR: 198.0, 165.9, 141.7, 140.1, 130.5, 129.5, 128.5, 126.5, 111.9, 104.7, 55.7, 45.6, 37.4, 31.4, 14.5; MS, m/z: 372.15 (M+). Anal. Calcd. For C21H24O6: C, 67.73; H, 6.50 O, 25.78 Found: C, 67.76; H, 6.51 O, 25.79%.

6-methoxy-4-(3, 4, 5-trimethoxyphenyl)-3, 4-dihydronaphthalen- 1(2H)-one 5b: Color: dark brown gummy solid. Yield: 75.18%. IR: 3128– 2939 (Ar-CH), 1697 (C=O); 1H NMR: 8.28–6.85 (5 H, m, Ar-H), 6.52(2 H, s, Ar-H), 4.04 (1 H, t, J = 4.7, CH), 3.80(12H, s, OCH3), 2.66–1.95 (4 H, t, J = 6.4, CH2); 13C NMR: 198.0, 165.9,153.6, 141.5, 137.5,136.7, 130.5, 126.5, 111.9, 106.7, 60.9, 56.1, 55.8, 45.9, 37.4, 31.4; MS, m/z: 342.15 (M+). Anal. Calcd. For C20H22O5: C, 70.16; H, 6.49 O, 23.36 Found: C, 70.17; H, 6.45 O, 23.39%.

6-methyl-4-(3, 4, 5-trimethoxyphenyl)-3, 4-dihydronaphthalen- 1(2H)-one 5c: Color: dark brown gummy solid. Yield: 71.94%. IR: 3125–2938 (Ar-CH), 1695 (C=O); 1H NMR: 7.80–7.13 (5 H, m, Ar-H), 6.52(2 H, s, Ar-H), 4.06 (1 H, t, J = 4.8, CH), 3.80(9H, s, OCH3), 2.65– 2.28 (4 H, t, J = 6.5, CH2), 2.34 (3 H, s, CH3); 13C NMR: 198.1, 153.4, 143.3, 140.4, 137.3, 136.7,131.4, 128.0,126.4, 125.2,106.7, 60.9, 56.3, 45.9, 37.5, 31.6, 21.6; MS, m/z: 326.14 (M+). Anal. Calcd. For C20H22O4: C, 73.60; H, 6.79 O, 19.61 Found: C, 73.61; H, 6.75 O, 19.69%.

4-(3, 4, 5-trimethoxyphenyl)-3, 4-dihydronaphthalen-1(2H)- one 5d: Color: dark brown gummy solid. Yield: 78.81%. IR: 3128–2935 (Ar-CH), 1691 (C=O); 1H NMR: 7.83–7.33 (6 H, m, Ar-H), 6.52(2 H, s, Ar-H), 4.02 (1 H, t, J = 4.6, CH), 3.83(9H, s, OCH3), 2.64–2.26 (4 H, t, J = 6.3, CH2). 13C NMR: 198.0, 153.4, 140.6, 140.5, 137.3, 136.7, 133.6, 128.1, 126.1, 106.1, 60.8, 56.5, 45.6, 37.6, 31.4, 14.9; MS, m/z: 312.07 (M+). Anal. Calcd. For C19H20O4: C, 73.06; H, 6.45 O, 20.49. Found: C, 73.07; H, 6.43, O, 20.50%.

Biological assays

Antimicrobial activity: Antibacterial activity of the synthesized compounds was determined against Gram-positive bacteria (Bacilus subtilius, Streptococcus) and Gram-negative bacteria (Escherichia coli, Proteus) in DMF by disc diffusion method on nutrient agar medium. The sterile medium (nutrient agar medium, 15 ml) in each petriplate was uniformly smeared with cultures of Gram-positive and Gramnegative bacteria. Sterile discs of 10 mm diameter (Hi-Media) was placed in the petriplates, to which different concentrations of drug (20 μg, 40, 80, 100 μg/disc) of the different synthesized compounds were added. Gentamycin was used as positive control for comparison. For each treatment, three replicates were maintained. The plates were incubated at 37 °C for 24 h and the zone of inhibition was determined.

Antioxidant assays

DPPH radical scavenging assay: DPPH radical reacts with an Anti-oxidant compound that can donate hydrogen and get reduced. DPPH, when acted upon by an Anti-oxidant, is converted into diphenyl picryl hydrazine. This can be identified by the conversion of purple to light yellow.

DPPH radical scavenging activity was done by the method of Shone et al. Briefly, 1 ml of DPPH solution (0.1 Mm, in 95% ethanol) was mixed with different concentration of compounds, shaken and incubated for 20 min at room temperature and absorbance was read at 517 nm against a blank. The radical scavenging activity was measured as the decrease in the absorbance of DPPH and calculated using the following equation:

Scavenging effect (%)=A control (540 nm)-A sample (540 nm)/A control (540 nm) × 100

Nitric oxide radical scavenging assay: Nitric oxide was generated from sodium nitroprusside and measured by the Griess reaction. Sodium nitroprusside, in aqueous solution at physiological pH, spontaneously generates nitric-oxide, which in turn reacts with oxygen to produce nitric ions that can be estimated by the Griess reagent spectrophotometrically at 540 nm.

Scavengers of nitric oxide compete with oxygen leading to reduced production of nitric oxide. Sodium nitroprusside (5 mM) in phosphate buffer saline was mixed with the compounds and incubated at 25°C for 120 minutes. The samples from the above were reacted with Griess reagent. The absorbance of the chromophore form during the diazotization of nitrate with sulphonyl amide and subsequent coupling with naphthyl ethylene diamine was read at 540 nm and refer to the absorbance standard solutions of BHT, treated in the same way with Griess reagent. The radical scavenging activity was measured using the equation described below

Scavenging effect (%)=A control (540 nm)-A sample (540 nm)/A control (540 nm) × 100

Anti-inflammatory activity

Inhibition of phospholipaseA2: The PLA2 obtained from viper venom were assayed by indirect hemolytic activity using the method of Boman and Kaletta Initially packed human erythrocyte, egg yolk and phosphate-buffered saline (1:1:8, v/v) were mixed. One ml of thus obtained suspension was incubated with the enzyme (10 μg), which was pre incubated with compounds of different concentrations for 10 min at 37°C. The reaction was stopped by adding 9 ml phosphate-buffered saline; the reaction mixture was centrifuged at 4°C for 10 min at 1500 rpm. The amount of haemoglobin released in the supernatant due to hemolysis was measured at 540 nm. The enzyme substrate mixture was used as positive control. Values are presented as the mean of three independent determinations.

Results and Discussion

Chemistry

The new tetralone analogues of podophyllotoxin were synthesized by chalcone route Scheme 1. Chalcones (3a-d) was prepared in high yields by Claisen-Schmidt reaction of acetophenone (1a-d) with 3,4,5-trimethoxybenzaldehyde in the presence of potassium hydroxide in water-ethanol mixture. The structures of the chalcones were confirmed by IR and 1H NMR spectra. IR spectra of compounds (2ad) showed the C=C stretching frequency in the range 1601-1591 cm-1 and 1H NMR showed the absence of aldehyde proton at 9.83 ppm. The cyclopropyl ketones (4a-d) were prepared in good yields by the Simmons-smith reaction of chalcones (2a-d) with diiodomethane in the presence of Zn-Cu couple in ether. Carbanion attacks nucleophilically the β-carbon atom of the chalcone which acts as Michael receptors to form an enolate ion, which undergoes nucleophilic attack on the methylene carbon atom to form the desired cyclopropyl ketones. The structures of compounds (4a-d) were confirmed by IR spectra. The IR spectra showed the C=O stretching band in the range 1664-1653 cm-1 and 1H NMR showed the cyclopropane CH and CH2 peak at the range 2.21-2.00 and 0.83-0.78 ppm respectively.

Tetralones (5a-d) were prepared in good yields by the cyclization reaction of cyclopropyl ketones (4a-d) in the presence of p-toluene sulphonic acid and acetic anhydride in dry dichloromethane. The cyclopropyl ketones undergoes electrophilic ring opening in the presence of Lewis acid to give benzyl carbocationic intermediate which attacked by aryl ring π-electrons resulting in the formation of a six membered ring with a pendant carbocation. This readily gives up proton to form tetralones. Acetic anhydride facilitates the formation of tetralones. In its IR spectra appeared absorption bands in the range 2923-2853 cm-1 and 1683-1675 cm-1 corresponds respectively to C-H and C=O stretching frequencies and 1H NMR of the ring B protons appears in the range 2.65-2.18 ppm. They are key intermediates for the synthesis of the novel nitrogen containing analogues of podophyllotoxin.

Anti-microbial activities

Compounds (5a, 5b, 5c, and 5d) were tested in vitro for their antimicrobial activity against 2 Gram-positive, 2 Gram-negative bacteria and a yeast type fungi C. albican strains. Commercial antibiotics such as Gentamycin and Flucanozole were used as reference drugs. The results were compared with reference drugs and depicted in the above table. The table reveals that 5a, 5b, 5d is potent compound of all the compounds which were under study with the MIC values ranging from 1.2 μg to 7 μg. Compounds 5c was not acting on Gram-positive bacteria such as B. subtilis. Compared to the reference compounds the activity of the tetralone derivatives is significant (Table 1).

Compounds Minimuminbitory concentration (µg)
S.aureus B.subtilis E.coli Proteus C.albicans
5a 3 7 4 3 1.4
5b 1.3 3.5 2.4 3 1.3
5c 3.5 - 3.5 4 55
 5d 1.2 3.3 2.3 2 1.2
Gentamycin 0.5 0.72 1 1.3 -
Flucanozole - - - - 0.75

Table 1: In vitro Anti-Microbial activities of synthesized compounds.

Antioxidant activities

DPPH radical scavenging assay: All the compounds of tetralin derivatives showed significant scavenging activity of the DPPH radicals compared to the reference compound BHT. Compounds 5a and 5c showed potent DPPH scavenging activity with an IC50 value of 16.89 μg/ mL, 17.24 μg/mL 18.12 μg/mL, 18.15 μg/mL, 18.75 μg/mL. Compound 5b showed less DPPH scavenging activity (Table 2 and Figure 2).

Compounds IC50µg/ml
5a 17.24
5b 35.62
5c 15.25
5d 25.83
BHT 37.4

Table 2: In vitro DPPH radical scavenging assay of synthesized compounds.

medicinal-chemistry-DPPH-radical-scavenging

Figure 2: DPPH radical scavenging assay of synthesized compounds.

Nitric oxide radical scavenging assay: All the tetralone derivatives showed the scavenging of nitric oxide radicals, scavenging is not significant compared to the reference compound BHT 6.4 μg/mL (Table 3 and Figure 3).

Compounds IC50  (µg/ml)
5a 30.62
5b 35
5c 30.62
5d 36
5e 31.25
BHT 6.4

Table 3: In vitro nitric oxide radical scavenging assay of synthesized compounds.

medicinal-chemistry-Nitric-oxide-radical

Figure 3: Nitric oxide radical scavenging assay.

Indirect hemolytic assay: The tetralin derivatives 2a and 4a showed the maximum inhibition with a IC50 value of 14.37 μg/mL, 13.78 μg/ mL and the other compounds showed moderate inhibition. A1 did not inhibit the enzyme (Table 4 and Figure 4).

Compounds IC50µg/ml
5a 12.53
5b 14.70
5c 18.25
5d 16.71

Table 4: PLA2 Inhibition of tetralone derivatives.

medicinal-chemistry-tetralone-derivatives

Figure 4: PLA2 Inhibition of tetralone derivatives.

Conclusion

The tetralone intermediates (5a-d) were prepared in good yield which are very essential for the synthesis and they showed good antimicrobial, anti-oxidant and anti-inflammatory activities.

Acknowledgement

The authors are thankful to University of Mysore for providing NMR, MASS and IR spectra.

References

 

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 8076
  • [From(publication date):
    August-2016 - Oct 20, 2017]
  • Breakdown by view type
  • HTML page views : 8000
  • PDF downloads :76
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords